Valuation Sanofi Borsa Italiana

Stocks

End-of-day quote Borsa Italiana 2026-09-22			5-day change	1st Jan Change
74.15 ^EUR	-0.56%		-0.34%	-10.71%

09-24	US FDA approves Lilly's once-weekly insulin injection for type 2 diabetes	RE
09-23	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	86,381	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-14.18%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	97,844	94,717	91,270
Change	-	-1.71%	1.04%	4.49%	-11.2%	-12.38%	-3.2%	-3.64%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	11.5x	10x	8.64x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.17x	1.1x	1.04x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-6.09x	0.7x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.81x	1.71x	1.62x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.05x	1.87x	1.72x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.64x	6.04x	5.37x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.35x	6.77x	6.03x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	11.8x	10.5x	9.07x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.49%	9.51%	11%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.254	4.496	4.795
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.9%	6.24%	6.65%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.279	7.206	8.348
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	67.7%	62.4%	57.4%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,648	50,644	53,167
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,728	15,673	16,990
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,312	13,999	15,142
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,479	8,886	10,309
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,463	8,336	4,889
Reference price ²	88.58	89.84	89.76	93.74	82.72	72.10	72.10	72.10
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,198,069	-	-
Announcement Date	2/4/22	2/3/23	2/1/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.72x	11.87x	24.12x	0.6%	1,026B
JOHNSON & JOHNSON	29.94x	6.66x	18.64x	2%	649B
ABBVIE INC.	33.52x	7.84x	16.21x	2.59%	468B
ROCHE HOLDING AG	19.75x	4.81x	11.92x	2.76%	352B
NOVARTIS AG	20.12x	5.24x	13.01x	3.05%	271B
ASTRAZENECA PLC	21.01x	4.36x	12.4x	2.03%	256B
AMGEN INC.	25.68x	6.7x	11.94x	2.48%	220B
GILEAD SCIENCES, INC.	-45.78x	6.66x	26.01x	2.17%	188B
NOVO NORDISK A/S	11.29x	4.12x	8.55x	4.45%	170B
Average	16.47x	6.47x	15.87x	2.46%	399.9B
Weighted average by Cap.	23.74x	7.73x	17.86x	1.99%